Bredt David
Chief Scientific Officer · 18 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-19 | RAPP | Rapport Therapeutics, Inc. | Option exercise | 6,000 | $1.80 | $10,800.00 | filing |
| 2026-02-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,400 | $28.95 | $156,328.38 | filing |
| 2026-02-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 2,200 | $29.59 | $65,107.68 | filing |
| 2026-02-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 900 | $28.02 | $25,218.99 | filing |
| 2026-01-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 8,300 | $26.83 | $222,651.65 | filing |
| 2026-01-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 200 | $27.40 | $5,480.00 | filing |
| 2025-12-31 | RAPP | Rapport Therapeutics, Inc. | Sale | 6,567 | $30.05 | $197,337.69 | filing |
| 2025-12-31 | RAPP | Rapport Therapeutics, Inc. | Award | 18,000 | — | — | filing |
| 2025-12-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 7,704 | $29.95 | $230,710.92 | filing |
| 2025-12-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 796 | $30.68 | $24,419.05 | filing |
| 2025-11-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 5,344 | $25.39 | $135,695.92 | filing |
| 2025-11-17 | RAPP | Rapport Therapeutics, Inc. | Sale | 3,156 | $24.84 | $78,394.72 | filing |
| 2025-10-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 7,418 | $25.73 | $190,886.65 | filing |
| 2025-10-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 1,082 | $26.16 | $28,309.56 | filing |
| 2025-08-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 8,300 | $14.98 | $124,308.27 | filing |
| 2025-08-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 200 | $15.79 | $3,158.00 | filing |
| 2025-07-15 | RAPP | Rapport Therapeutics, Inc. | Sale | 8,500 | $14.00 | $118,961.75 | filing |
| 2025-06-16 | RAPP | Rapport Therapeutics, Inc. | Sale | 8,500 | $11.00 | $93,522.10 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.